Drug Res (Stuttg) 2014; 64(11): 623-628
DOI: 10.1055/s-0034-1367037
Original Article
© Georg Thieme Verlag KG Stuttgart · New York

Assessment of Antibacterial Activity of Smaller Chain Tripeptides and Tetrapeptides

K. Nagarajan
1   Department of Pharmaceutical Chemistry, KIET School of Pharmacy, Ghaziabad, India
,
V. Kumar
2   Department of Pharmacology, KIET School of Pharmacy, Ghaziabad, India
,
P. K. Rai
1   Department of Pharmaceutical Chemistry, KIET School of Pharmacy, Ghaziabad, India
,
J. Singh
2   Department of Pharmacology, KIET School of Pharmacy, Ghaziabad, India
,
B. P. Panda
3   Microbial and Pharmaceutical Biotechnology Laboratory, Center for Advanced Research in Pharmaceutical Science, Jamia Hamdard University, New Delhi, India
,
L. K. Ghosh
4   Department of Pharmaceutical Technology, Jadavpur University, Kolkata, India
› Institutsangaben
Weitere Informationen

Publikationsverlauf

received 18. November 2013

accepted 19. Januar 2014

Publikationsdatum:
26. Februar 2014 (online)

Abstract

Our objective is to investigate the smaller chain tripeptides and tetrapeptides with the efforts mainly directed towards the identification of compounds presenting a high bactericidal activity. In this connection, 5 peptides, Met-Arg-Tyr (MRY), Met-Val-Tyr (MVY), Met-Ile-Cys-Tyr (MICY), Phe-Trp-Lys-Tyr (FWKY) and Met-Trp-Lys-Tyr (MWKY) were synthesized by solid phase peptide synthesis. The column eluted pure synthesized compounds were tested for in-vitro antibacterial disc diffusion assay using 2 g positive S. aureus, B.subtilis and 1 g negative E.coli bacterial strains at different concentrations predicted by pH and inhibitory concentration findings. 2 of the tetrapeptides, Phe-Trp-Lys-Tyr (FWKY) and Met-Trp-Lys-Tyr (MWKY) were found to be highly efficient against all the gram positive and microbial strains tested. Maximum activity was observed at a concentration of 300 µg/ml (499.17 µM) for the tetrapeptide Phe-Trp-Lys-Tyr (FWKY) against B. subtilis and at a concentration of 450 µg/ml (748.75 µM) against E. coli with the corresponding zonal inhibition diameter readings (17 mm; 16 mm). The tetrapeptide Met-Trp-Lys-Tyr (MWKY) was found to have high potency against S. aureus at a concentration of 450 µg/ml (769.23 µM) with the corresponding zonal inhibition diameter as 13 mm. The experimental results are analysed statistically by t-test at 5% and 1% level of significance. Our tetrapeptides have shown antibacterial action against both gram positive and gram negative strains and are considered safer as par with commercial antibiotics available today. Further clinical studies will make sure to position our potent small chain tetrapeptides in the arsenal of new broad spectrum anti-gram positive and anti-gram negative agent.

 
  • References

  • 1 Lehninger AL, David L, Nelson DL et al. Principles of Biochemistry. Delhi: CBS Publishers and Distributors; 1993
  • 2 Shawn D. Peptides and Proteins. Cambridge, UK: The Royal Society of Chemistry; 2002
  • 3 Couto MA, Harwig SSL, Cullor JS et al. eNAP-2, a novel cysteine rich bactericidal peptide from equine leukocytes. Infection and Immunity 1992; 60: 5042-5047
  • 4 Eisenhauer PB, Lehrer RI. Mouse neutrophils lack defensins. Infection and Immunity 1992; 60: 3446-3447
  • 5 Krause A, Neitz S, Magert HJ et al. LEAP-1, a novel highly disulfide-bonded human peptide, exhibits antimicrobial activity. FEBS Letters 2000; 480: 147-150
  • 6 Duclohier H. Antimicrobial peptides and peptaibols, substitutes for conventional antibiotics. Current Pharmaceutical Design 2010; 16: 3212-3223
  • 7 Bisht GS, Rawat DS, Kumar A et al. Antimicrobial activity of rationally designed amino terminal modified peptides. Bioorganic & Medicinal Chemistry Letters 2007; 17: 4343-4346
  • 8 Tam JP, Lu YA, Yang JL. Antimicrobial dendrimeric peptides. European Journal of Biochemistry 2002; 269: 923-932
  • 9 Laverty G, McLaughlin M, Shaw C et al. Antimicrobial activity of short, synthetic cationic lipopeptides. Chemical Biology & Drug Design 2010; 75: 563-569
  • 10 Liu Z, Deshazer H, Rice AJ et al. Multivalent antimicrobial peptides from a reactive polymer scaffold. Journal of Medicinal Chemistry 2006; 49: 3436-3439
  • 11 Liu Z, Brady A, Young A et al. Length effects in antimicrobial peptides of the (RW)n series. Antimicrobial Agents and Chemotherapy 2007; 51: 597-603
  • 12 Bera S, Zhanel GG, Schweizer F. Evaluation of amphiphilic aminoglycoside-peptide triazole conjugates as antibacterial agents. Bioorganic & Medicinal Chemistry Letters 2010; 20: 3031-3035
  • 13 Chanda S, Parekh J. In-vitro antimicrobial activity of some Indian folkfore medicinal plants. Journal of Cell and Tissue Research 2006; 6: 577-580
  • 14 Niidome T, Matsuyama N, Kunihara M et al. Effect of chain length of cationic model peptides on antibacterial activity. Bulletin of the Chemical Society of Japan 2005; 78: 473-476
  • 15 Bauer AW, Kirby WMM, Sherris JC et al. Antibiotic susceptibility testing by standardized single disc method. American Journal of Clinical Pathology 1996; 45: 493-496
  • 16 Greenwood D. Antimicrobial chemotherapy. New York: Oxford Univ. Press; 2000: 36
  • 17 Reiner R. Detection of antibiotic activity. In: Antibiotics an introduction. Switzerland: Roche Scientific Services; 1982: 21-25
  • 18 Kobayashi K, Pillai SK. Applied Statistics in Toxicology and Pharmacology. New Delhi: Oxford and IBH Publishing Co. Pvt. Ltd.; 2003: 19
  • 19 Lin J, Opuku A, Geheeb-keller M et al. Preliminary Screening of some traditional zulu medicinal plants for anti-inflammatory and anti-microbial activities. Journal of Ethnopharmacology 1999; 68: 267-274